BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Vitamin E
,
rs2230926
,
PPARA
,
Apoptosis
,
Lung cancer
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carboplatin
Summary
General Info
Curated Studies
Most Correlated Studies
Carboplatin sensitivity in ovarian carcinoma
Liver Pharmacology and Xenobiotic Response Repertoire
Lung cancer PC-9 parental cells or drug-treated and drug-tolerant persister (DTP) subpopulations
High grade serous ovarian carcinomas; carboplatin resistant fraction marked by CA125 expression
Rhabdomyosarcoma xenografts treated with ICE-T (ifosfamide, carboplatin, etoposide and paclitaxel)
Explore Curated Studies Results
Literature
Most Relevant Literature
Thermoresponsive carboplatin-releasing prodrugs.
Small extracellular vesicles loaded with carboplatin effectively enhance the cytotoxicity of drug-re…
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas.
Factors contributing to carboplatin blockade and interruption in its route of administration in pacl…
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients Wit…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trientine and Carboplatin in Advanced Malignancies
Validation of an Adjusted Dosing Algorithm of Carboplatin
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Carboplatin Periocular Injection for Retinoblastoma
Study of Vemurafenib, Carboplatin, and Paclitaxel
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ